These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2909265)

  • 1. Double-blinding in clinical trials.
    Ney PG
    CMAJ; 1989 Jan; 140(1):15. PubMed ID: 2909265
    [No Abstract]   [Full Text] [Related]  

  • 2. [How blind is a double-blind trial really? Validity of controlled investigations].
    Modestin J; Hodel J
    Int Pharmacopsychiatry; 1977; 12(3):129-36. PubMed ID: 334685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for clinical evaluation of antiepileptic drugs. Commission on Antiepileptic Drugs of the International League Against Epilepsy.
    Epilepsia; 1989; 30(4):400-8. PubMed ID: 2752994
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ethics of randomization].
    Arpaillange P; Dion S
    Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599
    [No Abstract]   [Full Text] [Related]  

  • 6. [Principles and regulations for clinical pilot studies on psycholeptic drugs (author's transl)].
    Woggon B; Angst J
    Arzneimittelforschung; 1978; 28(8):1257-9. PubMed ID: 380573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of blinding may be inappropriate after the trial.
    Hemilä H
    Contemp Clin Trials; 2005 Aug; 26(4):512-4; author reply 514-5. PubMed ID: 15951244
    [No Abstract]   [Full Text] [Related]  

  • 8. To throw the baby out with the bathwater: double blinding for specific oral tolerance induction.
    Longo G; Berti I; Barbi E
    Allergy; 2007 Jan; 62(1):82; author reply 83. PubMed ID: 17156347
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind assessment of therapeutic efficacy in clinical trials.
    Cohen S
    Dig Dis Sci; 1983 Jun; 28(6):564-5. PubMed ID: 6861586
    [No Abstract]   [Full Text] [Related]  

  • 10. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. News from the Society for Women's Health Research: subgroup analysis in clinical trials: detecting sex differences.
    Greenberger PE; Knab S
    J Womens Health Gend Based Med; 2002; 11(1):7-9. PubMed ID: 11860718
    [No Abstract]   [Full Text] [Related]  

  • 12. Critique of the Guidelines for Clinical Evaluation of Antianxiety Drugs (HEW-FDA-77-3043).
    Cohn JB; Gottschalk LA
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):313-5. PubMed ID: 45206
    [No Abstract]   [Full Text] [Related]  

  • 13. Trials evaluating antibiotics in rheumatoid arthritis: an overview.
    Chêne G; Lequen L; Schaeverbeke T
    Rev Rhum Engl Ed; 1999 Jan; 66(1 Suppl):67S-72S. PubMed ID: 10063530
    [No Abstract]   [Full Text] [Related]  

  • 14. The last patient in a drug trial.
    Hastings Cent Rep; 1981 Dec; 11(6):21-3. PubMed ID: 7333839
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for the clinical evaluation of antianxiety drugs. HEW (FDA) 77-3043, September 1977.
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):297-312. PubMed ID: 45205
    [No Abstract]   [Full Text] [Related]  

  • 16. Panel discussion on clinical trials: design.
    Forssman L
    Rheumatol Rehabil; 1978; Suppl():126-8. PubMed ID: 364603
    [No Abstract]   [Full Text] [Related]  

  • 17. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI; Present DH
    Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
    [No Abstract]   [Full Text] [Related]  

  • 18. Objective response criteria in phase II and phase III studies.
    Jones WG; Akaza H; Van Oosterom AT; Kotake T
    Prog Clin Biol Res; 1988; 269():243-60. PubMed ID: 3293063
    [No Abstract]   [Full Text] [Related]  

  • 19. Musing on Mathew et al.
    Kaniecki RG
    Headache; 2003 Sep; 43(8):922; author reply 924-8. PubMed ID: 14562838
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented).
    Pharmacopsychiatria; 1981 Sep; 14(5):190-9. PubMed ID: 7291302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.